Follow
Kalina Paunovska
Kalina Paunovska
Nava Therapeutics
Verified email at navatx.com
Title
Cited by
Cited by
Year
Drug delivery systems for RNA therapeutics
K Paunovska, D Loughrey, JE Dahlman
Nature Reviews Genetics 23 (5), 265-280, 2022
5132022
High-throughput in vivo screen of functional mRNA delivery identifies nanoparticles for endothelial cell gene editing
CD Sago, MP Lokugamage, K Paunovska, DA Vanover, CM Monaco, ...
Proceedings of the National Academy of Sciences 115 (42), E9944-E9952, 2018
2392018
A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation
K Paunovska, CD Sago, CM Monaco, WH Hudson, MG Castro, ...
Nano letters 18 (3), 2148-2157, 2018
1652018
Nanoparticles containing oxidized cholesterol deliver mRNA to the liver microenvironment at clinically relevant doses
K Paunovska, AJ Da Silva Sanchez, CD Sago, Z Gan, MP Lokugamage, ...
Advanced materials 31 (14), 1807748, 2019
1422019
Analyzing 2000 in Vivo Drug Delivery Data Points Reveals Cholesterol Structure Impacts Nanoparticle Delivery
K Paunovska, CJ Gil, MP Lokugamage, CD Sago, M Sato, GN Lando, ...
ACS nano 12 (8), 8341-8349, 2018
1092018
Species-dependent in vivo mRNA delivery and cellular responses to nanoparticles
MZC Hatit, MP Lokugamage, CN Dobrowolski, K Paunovska, H Ni, ...
Nature nanotechnology 17 (3), 310-318, 2022
622022
Using large datasets to understand nanotechnology
K Paunovska, D Loughrey, CD Sago, R Langer, JE Dahlman
Advanced Materials 31 (43), 1902798, 2019
572019
Treating cystic fibrosis with mRNA and CRISPR
A Da Silva Sanchez, K Paunovska, A Cristian, JE Dahlman
Human gene therapy 31 (17-18), 940-955, 2020
512020
Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands
Z Gan, MP Lokugamage, MZC Hatit, D Loughrey, K Paunovska, M Sato, ...
Bioengineering & translational medicine 5 (3), e10161, 2020
462020
Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery
C Dobrowolski, K Paunovska, E Schrader Echeverri, D Loughrey, ...
Nature Nanotechnology 17 (8), 871-879, 2022
402022
Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver
CD Sago, MP Lokugamage, D Loughrey, KE Lindsay, R Hincapie, ...
Nature biomedical engineering 6 (2), 157-167, 2022
372022
Therapeutic RNA delivery for COVID and other diseases
C Dobrowolski, K Paunovska, MZC Hatit, MP Lokugamage, JE Dahlman
Advanced healthcare materials 10 (15), 2002022, 2021
342021
The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo
A Radmand, MP Lokugamage, H Kim, C Dobrowolski, R Zenhausern, ...
Nano letters 23 (3), 993-1002, 2023
232023
Universal Barcoding Predicts In Vivo ApoE-Independent Lipid Nanoparticle Delivery
AJ Da Silva Sanchez, C Dobrowolski, A Cristian, ES Echeverri, K Zhao, ...
Nano Letters 22 (12), 4822-4830, 2022
232022
Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery
MZC Hatit, CN Dobrowolski, MP Lokugamage, D Loughrey, H Ni, C Zurla, ...
Nature Chemistry 15 (4), 508-515, 2023
222023
High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo
SG Huayamares, MP Lokugamage, R Rab, AJDS Sanchez, H Kim, ...
Journal of Controlled Release 357, 394-403, 2023
202023
Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery
AJDS Sanchez, K Zhao, SG Huayamares, MZC Hatit, MP Lokugamage, ...
Journal of Controlled Release 353, 270-277, 2023
202023
Characterization of polyethylene glycol–reinforced alginate microcapsules for mechanically stable cell immunoisolation
CA Verheyen, L Morales, J Sussman, K Paunovska, V Manzoli, ...
Macromolecular materials and engineering 304 (4), 1800679, 2019
202019
Increased PIP3 activity blocks nanoparticle mRNA delivery
K Paunovska, A Da Silva Sanchez, MT Foster, D Loughrey, EL Blanchard, ...
Science advances 6 (30), eaba5672, 2020
182020
The extent to which lipid nanoparticles require apolipoprotein E and low-density lipoprotein receptor for delivery changes with ionizable lipid structure
K Paunovska, AJ Da Silva Sanchez, MP Lokugamage, D Loughrey, ...
Nano Letters 22 (24), 10025-10033, 2022
122022
The system can't perform the operation now. Try again later.
Articles 1–20